PROKR1
Basic information
Region (hg38): 2:68643579-68658251
Previous symbols: [ "GPR73" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PROKR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 34 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 4 | 0 |
Variants in PROKR1
This is a list of pathogenic ClinVar variants found in the PROKR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-68645908-T-G | not specified | Likely benign (Oct 26, 2022) | ||
2-68645934-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
2-68646006-A-C | not specified | Uncertain significance (Aug 02, 2023) | ||
2-68646023-G-A | not specified | Uncertain significance (Oct 20, 2024) | ||
2-68646060-A-C | not specified | Uncertain significance (Dec 20, 2023) | ||
2-68646102-G-A | not specified | Uncertain significance (Jul 16, 2021) | ||
2-68646176-G-A | not specified | Conflicting classifications of pathogenicity (Oct 19, 2024) | ||
2-68646179-A-G | not specified | Uncertain significance (Oct 21, 2024) | ||
2-68646189-A-G | not specified | Uncertain significance (Sep 26, 2022) | ||
2-68646198-G-T | not specified | Uncertain significance (Sep 20, 2024) | ||
2-68646224-G-A | not specified | Likely benign (Aug 13, 2021) | ||
2-68646234-C-A | not specified | Uncertain significance (Jan 09, 2024) | ||
2-68646251-C-T | not specified | Uncertain significance (Nov 29, 2023) | ||
2-68646252-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
2-68646293-A-G | not specified | Uncertain significance (Jun 12, 2023) | ||
2-68654957-C-T | not specified | Uncertain significance (Aug 19, 2024) | ||
2-68654986-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
2-68654999-C-A | not specified | Uncertain significance (Dec 09, 2024) | ||
2-68655026-G-C | not specified | Uncertain significance (Jun 17, 2022) | ||
2-68655073-C-A | not specified | Likely benign (Jun 22, 2023) | ||
2-68655083-A-C | Long QT syndrome | Likely benign (-) | ||
2-68655149-A-G | not specified | Uncertain significance (May 03, 2023) | ||
2-68655166-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
2-68655212-G-T | not specified | Uncertain significance (Oct 04, 2024) | ||
2-68655266-C-G | not specified | Uncertain significance (Aug 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PROKR1 | protein_coding | protein_coding | ENST00000303786 | 2 | 11988 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.16e-7 | 0.109 | 125700 | 0 | 48 | 125748 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.341 | 248 | 233 | 1.06 | 0.0000156 | 2598 |
Missense in Polyphen | 65 | 66.547 | 0.97675 | 680 | ||
Synonymous | 0.695 | 90 | 98.8 | 0.911 | 0.00000732 | 798 |
Loss of Function | -0.346 | 10 | 8.89 | 1.13 | 3.93e-7 | 113 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000467 | 0.000467 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000230 | 0.000229 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for prokineticin 1. Exclusively coupled to the G(q) subclass of heteromeric G proteins. Activation leads to mobilization of calcium, stimulation of phosphoinositide turnover and activation of p44/p42 mitogen-activated protein kinase. May play a role during early pregnancy. {ECO:0000269|PubMed:18339712}.;
- Pathway
- Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.691
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.65
Haploinsufficiency Scores
- pHI
- 0.120
- hipred
- N
- hipred_score
- 0.338
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.312
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prokr1
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; vision/eye phenotype; skeleton phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;circadian rhythm
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;neuropeptide Y receptor activity